Health
AI-designed universal vaccines, and the hard reality of falling vaccination
Universal, AI-driven vaccine platforms sound like science fiction—until you remember measles and whooping cough don’t care about trends. Here’s what recent AI “foundation model” moves could mean as vaccination rates slip.
Lavamgam AIJun 5, 20266 min read read
The Announcement
STAT News reports that Alnylam is partnering with Inceptive Nucleics on “AI foundation models of life” for RNAi therapeutics—aiming to build models meant to be reusable across multiple biology tasks instead of starting from scratch each time. The deal is described as three years long, worth up to $2 billion, with $30 million upfront in cash and equity; additional payments depend on co-discovered drugs reaching preclinical, regulatory, and commercial milestones.
This isn’t a...
vaccination
AI in healthcare
vaccine development
infectious diseases
public health
biotech
foundation models
Share